机译:强效,选择性基于吡喃酮的Stromelysin-1抑制剂
Department of Chemistry and Biochemistry,Howard Hughes Medical Institute,Department of Pharmacology,Bioinformatics Program and Center for Theoretical Biological Physics,University of California,San Diego,La Jolla,California 92093;
Department of Chemistry and Biochemistry,Howard Hughes Medical Institute,Department of Pharmacology,Bioinformatics Program and Center for Theoretical Biological Physics,University of California,San Diego,La Jolla,California 92093;
Department of Chemistry and Biochemistry,Howard Hughes Medical Institute,Department of Pharmacology,Bioinformatics Program and Center for Theoretical Biological Physics,University of California,San Diego,La Jolla,California 92093;
Department of Chemistry and Biochemistry,Howard Hughes Medical Institute,Department of Pharmacology,Bioinformatics Program and Center for Theoretical Biological Physics,University of California,San Diego,La Jolla,California 92093;
Department of Chemistry and Biochemistry,Howard Hughes Medical Institute,Department of Pharmacology,Bioinformatics Program and Center for Theoretical Biological Physics,University of California,San Diego,La Jolla,California 92093;
机译:发现基质金属蛋白酶-3(间质溶素-1)的有效和选择性琥珀酰异羟肟酸酯抑制剂。
机译:基于吡喃酮的2型和3型金属蛋白酶抑制剂可作为构象选择性抑制剂
机译:基于吡喃酮的2型和3型金属蛋白酶抑制剂可作为构象选择性抑制剂
机译:磷脂酶A2的有效和选择性的2-氧代咪唑抑制剂作为治疗炎性疾病的新型药剂
机译:TAS05567,脾酪氨酸激酶的强效和选择性抑制剂,在炎症性疾病和B细胞恶性动物模型中的药理特性
机译:基于吡喃酮的2型和3型金属蛋白酶抑制剂可作为构象选择性抑制剂
机译:有效的,选择性吡喃酮基层抑制剂 - 1
机译:基于结构的stromelysin-1和mr1-mmp有效和选择性抑制剂的设计